Flualprazolams

Flualprazolam is a synthetic depressant of the triazolobenzodiazepine class and a fluorinated analog of alprazolam (Xanax). It first appeared on the research chemical market in 2017, though its developmental origins remain unclear. Flualprazolam is notably more potent than alprazolam, producing effects at lower doses with a relatively rapid onset. It has reportedly been deceptively sold as alprazolam despite differing in substantive ways, posing significant harm reduction concerns.

Also known as: F-alp, Flualp, 2'-fluoro-alprazolam

Classification

Chemical: Benzodiazepine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: GABAergic
Tag: Habit-Forming
Tag: Muscle Relaxant
Tag: Research-Chemical
Tag: Tentative

Effects

Sedation
Muscle Relaxation
Respiratory Depression
Headache
Physical Fatigue
Anxiety Suppression
Emotion Suppression
Thought Deceleration
Amnesia
Confusion
Motor Control Loss
Disinhibition
Dulled Perception

Routes of Administration

Oral

Dosage

Heavy: 1-2 mg
Light: 0.05 – 0.25 mg
Common: 0.25 – 0.5 mg
Strong: 0.5 – 1 mg
Threshold: 0.05 mg

Duration

Onset: 0.17-0.5 h
Peak: 1-2 h
Offset: 2-6 h
After Effects: 6-24 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu